Click here to view online

ORPHAN DRUGS AND RARE DISEASES EUROPE 2017
CROWNE PLAZA BERLIN, POTSDAMER PLATZ, BERLN, GERMANY
CONFERENCE: 15th - 16th MAY 2017 | WORKSHOPS: 17th MAY 2017
WEBSITE AGENDA CONTACT
 
We hope that you will be able to join us this May for the 6th annual Orphan Drugs and Rare Diseases Europe conference, taking place in Europe's largest pharmaceutical market, Berlin. 

With Germany currently possessing one of the toughest pricing mechanisms and policies in Europe, this year's Orphan Drugs conference is the perfect opportunity to unite and establish an interactive platform exploring how payers, pharma, biotech and patient organisations are preparing to participate and leverage the rapidly growing orphan drugs and rare diseases market.
EVENT NEWS
"...Of the 22 novel drugs approved by the FDA, the FDA approved 9 products with orphan designation, in line with the industry’s recent focus on rare disease..." *
REGISTER TODAY USING CODE SMI112J
TO SAVE AN ADDITIONAL 100

Our panel of pharmaceutical professionals will take the stage to discuss 'The sustainability of orphan drugs'. Which will shed light on just how crucial the c
ontinued research of orphan drugs and rare diseases truly is. Must hear topics of discussion will include:
  • Economic tools that improve access to orphan drugs
  • Sustainability of orphan drug reimbursement
  • How can we ensure the ongoing sustainability of orphan drugs?
  • Is there a correlation between sustainability and the cost-effectiveness and affordability?
Moderator: Carina Schey, Health Economist
Global Market Access Solutions
Panelists: Massimo Bertelli, Country Manager
Aegerion Pharmaceuticals
Robert Karl, Partner, RBV Capital
CONFERENCE
SPEAKERS
POST-CONFERENCE
WORKSHOPS
SPEAKER Workshops
Join like-minded industry experts in topical discussions and presentations on the most recent developments within the inherently niche orphan drugs market.

The complete speaker list is available here.
Don't forget to check out our CPD certified post conference workshops Wednesday 17th May 2017 here.

A: The impact of Brexit on the Orphan Drug Market 
08.30 - 12.30

B: Is the Party over, for orphans?
13.30 - 17.30

JOIN US THIS MAY

REMINDER: THE 100 EARLY BIRD DISCOUNT WILL EXPIRE SOON!

REGISTER ONLINE TODAY TO SECURE YOUR SPACE.

SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please contact:

Alia Malick | +44 (0) 20 7827 6168 | email: amalick@smi-online.co.uk

For delegate enquiries please contact:
Adolis Miniauskas |+44 (0) 207 827 6744 | email: aminiauskas@smi-online.co.uk

We look forward to meeting you,
The Orphan Drugs and Rare Diseases Europe 2017 Team       
OD 17 Banner

CLICK HERE TO UNSUBSCRIBE

www.pharmaceutical-tech.com - Fully owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555